Janelle F. Ruisinger

Janelle Ruisinger
  • Associate Dean for Academic Affairs
  • Clinical Professor
  • School of Pharmacy, Administration
  • Department of Pharmacy Practice

Contact Info

785-864-6369
School of Pharmacy, Room 3045-B
2010 Becker Drive
Lawrence, KS 66047-1620

Biography —

Janelle F. Ruisinger is associate dean of academic affairs and clinical professor of pharmacy practice. She received her Doctor of Pharmacy degree from The University of Kansas School of Pharmacy then completed a PGY1 residency with a emphasis on community care at the Ohio State University. She joined the KU School of Pharmacy in 2000 and served as the director of the KU Community Pharmacy Residency Program and a clinical pharmacist in the KU Medical Center Atherosclerosis and LDL-Apheresis Center. Her teaching and research interests include pharmacy residencies and ambulatory/community care.

Education —

PGY1 Residency (emphasis on Community Care), The Ohio State University College of Pharmacy, Columbus, OH
Pharm.D., The University of Kansas School of Pharmacy, Lawrence, KS

Teaching —

Courses Taught

  • Pharmacotherapy I – instructor
  • Pharmacotherapy V – co-coordinator
  • Introduction to Pharmacy Residencies – co-coordinator and instructor
  • Medical Terminology elective – co-coordinator
  • Introduction to the Pharmaceutical Industry - co-coordinator
  • Hematology/Oncology Pharmacy – co-coordinator
  • Medication Safety and Error Prevention - co-coordinator
  • Practical Pediatrics – co-coordinator
  • Introduction to Pharmacy - co-coordinator and instructor

Selected Publications —

  • Moore MS, Ruisinger JF, Johnson LM, Melton BL. Assessing the Effects of Pharmacist Education on Colorectal Cancer Screening and Access to a Stool-based DNA Test.  J Am Pharm Assoc (2023), doi: https://doi.org/10.1016/j.japh.2022.11.012
  • Herrman A, Ruisinger JF, Moore EE, Melton BL, Assessing the Impact of a Pharmacy Provided Personalized Vaccination Recommendation on Immunization Rates of Adolescents, J Am Pharm Assoc (2023), doi: https://doi.org/10.1016/j.japh.2022.10.017.
  • Newell BJ, Melton BL, Burkhardt CD, Ruisinger JF. Semaglutide Initiation in a Type 2 Diabetes Mellitus, Post-Liver Transplant Patient. Sr Care Pharm. 2022 Jun 1;37(6):221-226. doi: 10.4140/TCP.n.2022.221. PMID: 35610766.
  • Carmosino E, Ruisinger JF, Kinsey JD, Melton BL. Vaccination approval literacy and its effects on intention to receive future COVID-19 immunization. J Am Pharm Assoc (2003). 2022 Jan 6:S1544-3191(22)00001-2. doi: 10.1016/j.japh.2022.01.001. Epub ahead of print. PMID: 35065886
  • Dollar KJ, Ruisinger JF, Graham EE, Prohaska ES, Melton BL. Public awareness of Mental Health First Aid and perception of community pharmacists as Mental Health First Aid providers. J Am Pharm Assoc. 2020 Sep-Oct;60(5S):S93-S97.e1. doi: 10.1016/j.japh.2020.01.017. Epub 2020 Mar 2. PMID: 32139284.
  • Seipel MBA, Prohaska ES, Ruisinger JF, Melton BL. Patient Knowledge and Experiences With Antibiotic Use and Delayed Antibiotic Prescribing in the Outpatient Setting. J Pharm Pract. 2019 Dec 13:897190019889427. doi: 10.1177/0897190019889427. Epub ahead of print. PMID: 31835961.
  • Luchen GG, Prohaska ES, Ruisinger JF, Melton BL. Impact of community pharmacist intervention on concurrent benzodiazepine and opioid prescribing patterns. J Am Pharm Assoc 2018. https://doi.org/10.1016/j.japh.2018.10.010. Epub 2018 Dec 11.
  • Backes JM, Melton BL, Ruisinger JF, Burkhardt CD, Moriarty PM. Comparing patients' prescribed, self-reported, and actual intake of supplemental eicosapentaenoic acid + docosahexaenoic acid. J Clin Lipidol 2018. https://doi.org/10.1016/j.jacl.2018.11.005. Epub 2018 Nov 15.
     

Selected Presentations —

  • Ruisinger JF. Time to Update Your (Lipid) Profile: Community Pharmacy Management of Hyperlipidemia. McKesson 2024 ideaShare Conference, New Orleans, LA.
  • Case E, Ruisinger JF, Johnson L, Melton B (2023). Assessing Pharmacist Knowledge, Comfort, and Willingness in Prescribing Smoking Cessation Therapy. Presented at the American Pharmacists Association Annual Meeting, Phoenix AZ. Abstract and poster. Journal of the American Pharmacists Association. 2023;63(4):1395-96.
  • Ruisinger JF. CETP Inhibitors: Troubled Past but Brighter Future? National Lipid Association Scientific Sessions, Scottsdale, AZ. June 2022
  • Pauling EE, Ruisinger JF. Training Residents on the Pharmacists’ Patient Care Process. American Pharmacists Association Annual Meeting, Seattle, WA. March 2019
  • Ruisinger JF, Saseen J. Your Annual Cholesterol Management Update: Reducing ASCVD Risk. American Pharmacists Association Annual Meeting, Seattle, WA. March 2019

Awards & Honors —

  • Fellow of the American Pharmacists Association, March 2016 
  • Appointed to the Commission on Credentialing, American Society of Health-System Pharmacists (August 2013 - December 2019)
  • American Pharmacists Association Distinguished Achievement Award in Pharmacy Practice (2013)

Memberships —

  • American Pharmacists Association
  • American Society of Health-System Pharmacists
  • Kansas Pharmacists Association